Loading organizations...
Mediately develops a leading medical application that provides doctors with essential drug information, clinical decision support tools, and accredited medical education. The company's core product is a fast and intuitive mobile assistant designed to streamline access to critical medical knowledge, enabling healthcare professionals to make informed decisions efficiently at the point of care. This technology aids in discovering new drugs, verifying dosages, understanding side effects, and navigating complex medical guidelines.
The company originated in 2011 as Modra Jagoda d.o.o., founded by Blaž Triglav, Marko Nikolovski, and Nejc Tomšič. Their initial offering, the "Register zdravil" app, launched in 2012, with the Mediately brand established the following year. The founders identified a critical need to simplify and expedite medical knowledge accessibility, driven by the insight that empowering doctors with readily available, accurate information directly improves patient care and professional development.
Mediately's product serves doctors and healthcare professionals across numerous countries, offering tailored functionalities that cater to various medical specialties. Users can check drug summaries, utilize clinical calculators for precise dosing, and search the ICD-10 classification system. The company's overarching mission is to empower medical practitioners with comprehensive knowledge, ultimately helping them treat patients more effectively and continuously advance their expertise.
Mediately has raised $8.3M across 3 funding rounds.
Mediately has raised $8.3M in total across 3 funding rounds.
Mediately is a leading medtech company that builds a medical app and digital platform designed to help doctors and healthcare professionals access localized, relevant drug information, clinical decision support tools, and accredited medical education. It serves physicians across multiple European countries, enabling them to make better-informed decisions by simplifying complex medical knowledge. The platform addresses the critical problem of information overload and fragmented medical data, improving treatment quality and efficiency. Mediately has demonstrated strong growth momentum, expanding its presence across 14 countries in Central and Eastern Europe and Western Europe, supported by a recent €7.2 million Series A funding round to accelerate further expansion[3][7].
Founded in 2011 by Blaž Triglav, Marko Nikolovski, and Nejc Tomšič, Mediately emerged from a shared mission to make medical knowledge accessible and actionable for doctors. The first app was released in 2012, and the Mediately brand was launched in 2013. The founders combined expertise in medicine, digital pharma marketing, and software development to create a fast, intuitive mobile assistant for healthcare professionals. Early traction included rapid adoption in Slovenia and subsequent expansion into the Czech Republic, Italy, Spain, Germany, France, Poland, and Hungary. The company’s growth has been marked by continuous product development and recognition within the medical and tech communities[3].
Mediately rides the growing trend of digital transformation in healthcare, particularly the increasing demand for clinical decision support and real-time access to reliable medical information. The timing is critical as healthcare systems across Europe face rising complexity, regulatory changes, and a need for efficiency gains. Market forces such as the proliferation of mobile devices among clinicians, the push for evidence-based medicine, and the digitization of pharmaceutical data favor Mediately’s solution. By improving doctors’ access to actionable knowledge, Mediately influences the broader ecosystem by enhancing patient care quality, reducing medication errors, and supporting healthcare professionals’ continuous learning[3][7].
Looking ahead, Mediately is poised to deepen its footprint across Europe and potentially beyond, leveraging its strong funding base and expert team. Trends shaping its journey include the integration of AI for personalized clinical insights, expansion of educational content, and partnerships with healthcare institutions and pharma companies. As digital health adoption accelerates, Mediately’s influence is likely to grow, positioning it as a key enabler of smarter, data-driven healthcare decisions. Its mission to empower doctors with accessible knowledge ties back to its origin, promising sustained impact on medical practice and patient outcomes[3][7].
Mediately has raised $8.3M across 3 funding rounds. Most recently, it raised $8.0M Series A in February 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 1, 2022 | $8M Series A | Piton Capital | ALL Iron Ventures, Bond, Charlotte Street Capital, Dawn Capital, LAUNCHub Ventures, Seaya Ventures, VentureFriends, Wndrco LLC, Justin Mateen, Klaus Nyengaard, Sergio Furio, Silicon Gardens | Announced |
| Mar 1, 2015 | $110K Seed | — | Dawn Capital, LAUNCHub Ventures | Announced |
| Feb 1, 2014 | $140K Seed | — | Dawn Capital, LAUNCHub Ventures | Announced |
Mediately has raised $8.3M in total across 3 funding rounds.
Mediately's investors include Piton Capital, All Iron Ventures, Bond, Charlotte Street Capital, Dawn Capital, LAUNCHub Ventures, Seaya Ventures, VentureFriends, WndrCo LLC, Justin Mateen, Klaus Nyengaard, Sergio Furio.
